Stonehenge Inter PCL (BKK:STI) COGS-to-Revenue : 0.73 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Stonehenge Inter PCL COGS-to-Revenue?

Stonehenge Inter PCL's Cost of Goods Sold for the three months ended in Dec. 2023 was ฿289 Mil. Its Revenue for the three months ended in Dec. 2023 was ฿396 Mil.

Stonehenge Inter PCL's COGS to Revenue for the three months ended in Dec. 2023 was 0.73.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Stonehenge Inter PCL's Gross Margin % for the three months ended in Dec. 2023 was 27.20%.

Stonehenge Inter PCL COGS-to-Revenue Historical Data

The historical data trend for Stonehenge Inter PCL's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stonehenge Inter PCL COGS-to-Revenue Chart

Stonehenge Inter PCL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

COGS-to-Revenue

Get a 7-Day Free Trial

0.67

0.68

0.66

0.68

0.71

Stonehenge Inter PCL Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.67	0.71	0.71	0.73	0.73

Stonehenge Inter PCL COGS-to-Revenue Calculation

Stonehenge Inter PCL's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1225.704	/	1732.804
	=	0.71

Stonehenge Inter PCL's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	288.597	/	396.434
	=	0.73

Stonehenge Inter PCL (BKK:STI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Stonehenge Inter PCL's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	288.597 / 396.434
	=	27.20 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Stonehenge Inter PCL COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Stonehenge Inter PCL's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Stonehenge Inter PCL (BKK:STI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Stonehenge Inter PCL (BKK:STI) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ratchadaphisek Road, 163 Chokechairuammitr (Ratchada19), Dindaeng District, Dindaeng, Bangkok, THA, 10400

Website

https://www.sti.co.th

Stonehenge Inter PCL is engaged in consulting & construction management services and the design of architectural & engineering services. Its portfolio includes residential buildings, commercial & offices, educational buildings, hospitals & clinics, factories & warehouses, hotels & resorts, and housing. Its services include architectural and engineering design services, interior decoration and the preservation of ancient sites, consultancy, administration, and construction control. The company derives a vast majority of the revenues from the Consulting and management services segment.

Stonehenge Inter PCL (BKK:STI) Headlines

From GuruFocus

Thinking about buying stock in ZIM Integrated Shipping, Solidion Technology, SoundHound AI, Longboard Pharmaceuticals, or Xpeng?

By PRNewswire • 02-12-2024